A Study of SHR-1501 in Patients With Advanced Tumors

Clinical trial NCT04025957 · COMPLETED

Trial details

NCT number: NCT04025957
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2019-10-30
Primary completion: 2022-07-31
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.